Site-Specific Serine Incorporation by Lif and Epr into Positions 3 and 5 of the Staphylococcal Peptidoglycan Interpeptide Bridge
暂无分享,去创建一个
W. Schröder | B. Berger-Bächi | M. Tschierske | K. Ehlert | Brigitte Berger-Bächi | C. Mori | Kerstin Ehlert | Martin Tschierske | Claudio Mori | Werner Schröder
[1] L. Heath,et al. The lysostaphin endopeptidase resistance gene (epr) specifies modification of peptidoglycan cross bridges in Staphylococcus simulans and Staphylococcus aureus , 1995, Applied and environmental microbiology.
[2] F. Götz,et al. Studies on prolysostaphin processing and characterization of the lysostaphin immunity factor (Lif) of Staphylococcus simulans biovar staphylolyticus , 1997, Molecular microbiology.
[3] B. Berger-Bächi,et al. Influence of femB on methicillin resistance and peptidoglycan metabolism in Staphylococcus aureus , 1993, Journal of bacteriology.
[4] B. Berger-Bächi,et al. Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus , 1997, Journal of bacteriology.
[5] B. Berger-Bächi,et al. The essential Staphylococcus aureus gene fmhB is involved in the first step of peptidoglycan pentaglycine interpeptide formation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[6] J. Robinson,et al. Relationship between lysostaphin endopeptidase production and cell wall composition in Staphylococcus staphylolyticus , 1979, Journal of bacteriology.
[7] B. Berger-Bächi,et al. Lif, the lysostaphin immunity factor, complements FemB in staphylococcal peptidoglycan interpeptide bridge formation. , 1997, FEMS Microbiology Letters.
[8] W. Schröder,et al. Specificities of FemA and FemB for different glycine residues: FemB cannot substitute for FemA in staphylococcal peptidoglycan pentaglycine side chain formation , 1997, Journal of bacteriology.
[9] M. Sugai,et al. epr, which encodes glycylglycine endopeptidase resistance, is homologous to femAB and affects serine content of peptidoglycan cross bridges in Staphylococcus capitis and Staphylococcus aureus , 1997, Journal of bacteriology.
[10] H. Labischinski,et al. Staphylococcal peptidoglycan interpeptide bridge biosynthesis: a novel antistaphylococcal target? , 1996, Microbial drug resistance.
[11] P. Edman,et al. A protein sequenator. , 1967, European journal of biochemistry.